Yasuhiro Hayami, Chief Business Officer at MEDIROM Mother Labs, has made a second investment in the company's Series A financing, valuing it at JPY9 billion, reflecting confidence in its innovative health-tech offerings.
Target Information
MEDIROM Mother Labs Inc. is a subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) based in Tokyo, Japan. The company operates within the health-tech industry and is committed to developing innovative health solutions. Its flagship product, the MOTHER Bracelet, is the world's first 24/7 recharge-free smart tracker, utilizing advanced technology to monitor various health metrics continuously without the need for recharging.
Mother Labs focuses on customizable health management solutions through its “Specific Health Guidance Program” delivered via the “Lav” health application. The integrative approach allows it to serve diverse sectors, including caregiving, logistics, and manufacturing, thus broadening its market reach and impact.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The health-tech sector in Japan has been experiencing rapid growth driven by increasing consumer awareness around health and wellness technologies. The demand for wearable devices has surged, fueled by advancements
Similar Deals
Catalys Pacific and SR One → Renalys Pharma, Inc.
2024
Yasuhiro Hayami
invested in
Mother Labs
in 2025
in a Series A deal
Disclosed details
Transaction Size: $60M
Enterprise Value: $9M
Equity Value: $60M